Resources

Type of publications
Regions
Diseases

5192 results found

2021 ∙ Rotshild, V. Hirsh-Raccah, B. Miskin, I. Muszkat, M. Matok, I.

Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Schnyder, J. L. Garcia Garrido, H. M. De Pijper, C. A. Daams, J. G. Stijnis, C. Goorhuis, A. Grobusch, M. P.

Comparison of equivalent fractional vaccine doses delivered by intradermal and intramuscular or subcutaneous routes: A systematic review

  • All age groups
  • Hepatitis B
  • Human papillomavirus (HPV)
  • Influenza
  • Measles
  • Meningococcal disease
  • Rabies
  • Poliomyelitis
  • Varicella
  • Efficacy/effectiveness
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Lin, C. Tu, P. Beitsch, L. M.

Confidence and receptivity for covid‐19 vaccines: A rapid systematic review

  • All age groups
  • Parents/caregivers
  • Healthcare workers
  • COVID-19
  • Acceptance
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Linertova, R. Guirado-Fuentes, C. Mar Medina, J. Imaz-Iglesia, I. Rodriguez-Rodriguez, L. Carmona-Rodriguez, M.

Cost-effectiveness of extending the HPV vaccination to boys: a systematic review

  • Adolescents
  • Human papillomavirus (HPV)
  • Economic aspects
  • Administration
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Shi, W. Cheng, X. Wang, H. Zang, X. Chen, T.

Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies

  • Western Pacific
  • China
  • All age groups
  • Human papillomavirus (HPV)
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Shao, Y. Stoecker, C.

Cost-effectiveness of pneumococcal vaccines among adults over 50 years old in low- and middle-income countries: a systematic review

  • Adults
  • Older adults
  • Low and Middle Income Countries
  • Pneumococcal disease
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Hong, K. Leidner, A. J. Tsai, Y. Tang, Z. Cho, B. H. Stokley, S.

Costs of Interventions to Increase Vaccination Coverage Among Children in the United States: A Systematic Review

  • Americas
  • United States of America
  • Newborn
  • Children
  • Adolescents
  • Economic aspects
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2021 ∙ Jacobs, J. W. Booth, G. S.

COVID-19 and Immune-Mediated RBC Destruction

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Falsaperla, R. Leone, G. Familiari, M. Ruggieri, M.

COVID-19 vaccination in pregnant and lactating women: a systematic review

  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2021 ∙ Al-Amer, R. Maneze, D. Everett, B. Montayre, J. Villarosa, A. R. Dwekat, E. Salamonson, Y.

COVID-19 vaccination intention in the first year of the pandemic: A systematic review

  • All age groups
  • Healthcare workers
  • Parents/caregivers
  • COVID-19
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
Loading...